Prot# PRX302-2-06: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Multicenter Safety and Efficacy Study of a Single Transrectal Intraprostatic Treatment of PRX302 for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Project: Research project

Project Details

StatusFinished
Effective start/end date11/29/11 → 11/29/14

Funding

  • i3 (PRX302-2-06 // PRX302-2-06)
  • Protox Therapeutics Inc. (PRX302-2-06 // PRX302-2-06)